Compare Baxter International Inc (BAX) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Tesla, Inc. — how do they compare? Baxter International Inc trades at $22.38 (market cap $11.26B), while Tesla, Inc. trades at $395.26 (market cap $1.49T). The key difference: Tesla, Inc. is far larger — about 132.3× Baxter International Inc's market cap, and Baxter International Inc pays a 0.92% dividend while Tesla, Inc. pays none. Which is the better fit depends on your goals.
| BAX | TSLA | |
|---|---|---|
Market Cap | $11.26B | $1.49T |
Sector | Health | Consumer Cyclical |
52-Week High | $29.22 | $489.88 |
52-Week Low | $15.80 | $302.63 |
Enterprise Value | $18.93B | $1.46T |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Baxter International (BAX) trades at $22.57, down 0.22% on the day, with mixed technical signals showing a bullish moving average trend but neutral oscillators. The company reported Q1 2026 earnings beat with $0.36 EPS versus $0.31 expected, though net income margin remains negative at -9.7%. Recent news highlights upcoming Q2 earnings call and sustainability initiatives, while analyst consensus sits at $22.67 price target with 42% buy ratings.
BAX faces fundamental challenges with negative profitability metrics and volatile cash flow, but valuation appears reasonable with P/S of 1.02. The stock offers potential upside to analyst targets if operational improvements materialize, though investors must weigh high debt levels and inconsistent earnings performance against turnaround prospects in the medical technology sector.
Tesla (TSLA) trades at $396.87, up 0.53% with mixed technical signals showing bearish moving averages but neutral oscillators. The company faces valuation challenges with a P/E ratio of 363.47 and declining profit margins, though recent earnings beat expectations in Q1 2026. Positive developments include regulatory approval for self-driving software in Europe and strong growth in German registrations.
Tesla's outlook balances innovation potential against execution risks. The stock offers exposure to autonomous driving leadership and energy growth, but faces intense EV competition and margin pressure. Analyst consensus price target of $409.26 suggests modest upside, though institutional sentiment remains divided with 39.5% buy ratings versus 18.5% sell recommendations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
